SGMO – Abstracts

The SGMO ICAAC abstracts are now available. This links to the late breaker abstract. Abstract: Background: Expression of CCR5 by CD4 cells is necessary for productive R5 HIV infection. Biallelic.

September 10- EOD

Decent day in the market but biotechs did not seem to participate to the same extent. Of course, I do not have much time to follow the market on Tuesday.

September 9- EOD

Some interesting news today and generally a positive market environment, although some of the recent high fliers seemed to take most of the day off. That is not completely surprising.

September 6- EOD

The week ended with some interesting action and volatility over Syria news. The markets appear jumpy but note that the sell off was over the words of Putin. I think.

September 6- EOD

The week ended with some interesting action and volatility over Syria news. The markets appear jumpy but note that the sell off was over the words of Putin. I think.

September 6- EOD

The week ended with some interesting action and volatility over Syria news. The markets appear jumpy but note that the sell off was over the words of Putin. I think.

September 5- EOD

As I noted before, Tuesday and Thursday will likely be shorter updates given my schedule but there is some important news that came out for some companies that I want.

September 4- EOD

There was some nice action in biotech land today despite not being particularly busy in terms of news. There was some interesting stock specific action and the sector was a.

September 3- EOD

I am going to try and cover what was a fairly busy day in biotech land but Tuesday and Thursday will necessarily be shorter than usual. The semester has started.

August 30- EOD

Well, perhaps this is the last time I will write this for awhile but a slow day in the market and news front. I guess it makes sense as the.

August 29- EOD

We got a trickle of some interesting biotech news but still nothing dramatic. I suspect that the pace will increase in September as the summer ends and the fall healthcare.

August 28- EOD

Again, it is a quite day in the biotech realm as the market essentially treads water waiting for the strike on Syria before deciding on its next direction. The market.

August 27- EOD

I have bemoaned about slow days before but very little biotech news today. I will do some more macro Syria coverage and some tidbits from the biotech world. That being.

August 26- EOD

The week is off to a good start with the end of the ONXX/AMGN saga and some strong moves in biotech land. There is not a lot of stock specific.

August 22- EOD

A quiet day after the relatively interesting data release of INCY yesterday. Of course, it was forced quiet as the market broke for most of the day. There is really.

August 21- Midday

There was certainly some interesting news today with INCY and I wanted to spend time going through the results as they actually raise as many questions as answers. I also.

August 20-EOD

There was really nothing special on the news front today but I guess we were getting a little spoiled with the VICL, MNKD, and GTXI data all coming out in.

August 19- EOD

Somewhat of a decent start to the week but unfortunately it appears like more of the same in term of general biotech sentiment and news flow. There are a couple.

August 16- EOD (kind of)

This is a Friday in August and so it is not surprising that it was light on the news front as well as it being another low volume chop fest..

August 15- EOD

Markets started off weak again and biotechs followed down. Outside of the conference call from MNKD there was not much news in terms of data. Perhaps it is this lack.

Browsing 20 / articles